… To compare the effects of dapagliflozin vs. placebo on the primary outcome and secondary
clinical outcomes in patients with ischaemic and non-ischaemic aetiology, respectively, time-…

… The effects of dapagliflozin on different natriuretic and diuretic responses are presented
in Table 3. Spot urinary Na concentration 2 h after randomization was modestly higher in the …

Introduction Chronic obstructive pulmonary disease (COPD) is a common comorbidity in heart
failure (HF) with preserved ejection fraction (HFpEF) and associated with worse outcomes…

… glycaemic effects of dapagliflozin only modestly contribute in reducing the risk of kidney
outcomes. Non-glycaemic effects of dapagliflozin… suggested beneficial effects of dapagliflozin on …

… Single-centre open label observational pilot trial, to investigate the short-term effects of
dapagliflozin in consecutive heart failure and reduced ejection fraction patients with elevated …

… The Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure (DAPA-HF) trial
has demonstrated the effects of dapagliflozin in patients with HFrEF by reducing HF …

… heart failure events (defined as either unplanned hospitalization or urgent heart failure visit
… included the total number of heart failure events (hospitalization for heart failure, urgent …

… the prognostic importance of hyponatremia and the effects of dapagliflozin on serum sodium
in the DAPA-HF (Dapagliflozin And Prevention of Adverse outcomes in Heart Failure) trial. …

… This analysis, which evaluates the treatment effects of dapagliflozin according to baseline
NT-proBNP levels in patients with HFmrEF or HFpEF. This is particularly relevant, as elevated …

… risk of worsening heart failure and death in patients with heart failure with reduced ejection
… of changes in hsTnT over time, the effects of dapagliflozin on clinical outcomes in relation to …